Across studies investigating the impact of tirzepatide treatment on food- and appetite-related assessments (Table S1), tirzepatide treatment was generally associated with reduced overall fasting appetite, including reduced hunger, increased fullness, and reduced prospective food intake compared with placebo, liraglutide, and semaglutide
Venneti, K.C., Malthouse, J.P., O'Harte, F.P., Hewage, C.M
Work with a knowledgeable provider if you are considering combinations
When used in conjunction with diet and exercise, it can lead to significant weight loss which in turn reduces the incidence of diabetes, hypertension and reduces the risk of cancer